Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $45.6500 (1.22%) ($44.3000 - $45.8000) on Thu. Jun. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.75% (three month average) | RSI | 36 | Latest Price | $45.6500(1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(51%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.875% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-11%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.875% (StdDev 3.75%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
Resistance Level | $47.75 | 5 Day Moving Average | $44.51(2.56%) | 10 Day Moving Average | $45.79(-0.31%) | 20 Day Moving Average | $47.75(-4.4%) | To recent high | -11.3% | To recent low | 29.9% | Market Cap | $3.392b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |